| Name | Cvs Pharmacy #02735 |
|---|---|
| Organization Name | Ohio Cvs Stores Llc |
| Location | 4280 Morse Rd, Columbus, Ohio 43230 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (614) 473-1123 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
In a randomized trial performed to help resolve the uncertainty about the optimal oxygen saturation therapy in extremely preterm infants, researchers found that targeting saturations of 85 percent to 89 percent compared with 91 percent to 95 percent had no significant effect on the rate of death or disability at 18 months, according to a study published by JAMA. The study is being released early online to coincide with its presentation at the Pediatric Academic Societies annual meeting.
Sorrento Therapeutics, Inc. announced today that it has entered into an exclusive licensing agreement to develop and commercialize multiple prespecified and undisclosed biosimilar or biobetter antibodies from Mabtech Limited, a holding company for premier antibody development and manufacturing companies in China.
A new study investigated the antiviral activity and mechanism of action of Brilacidin against multiple human coronaviruses.
An editorial published today in The Lancet Neurology calls for sports authorities to take into consideration the long term neurological problems that repeated concussions can cause.
In a new study, scientists at the National Institutes of Health took a molecular-level journey into microtubules, the hollow cylinders inside brain cells that act as skeletons and internal highways.
› Verified 6 days ago
| NPI Number | 1629172457 |
| Organization Name | OHIO CVS STORES LLC |
| Doing Business As | CVS PHARMACY #02735 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 4280 Morse Rd, Columbus, OH 43230 |
| Phone Number | 614-473-1123 |
News Archive
In a randomized trial performed to help resolve the uncertainty about the optimal oxygen saturation therapy in extremely preterm infants, researchers found that targeting saturations of 85 percent to 89 percent compared with 91 percent to 95 percent had no significant effect on the rate of death or disability at 18 months, according to a study published by JAMA. The study is being released early online to coincide with its presentation at the Pediatric Academic Societies annual meeting.
Sorrento Therapeutics, Inc. announced today that it has entered into an exclusive licensing agreement to develop and commercialize multiple prespecified and undisclosed biosimilar or biobetter antibodies from Mabtech Limited, a holding company for premier antibody development and manufacturing companies in China.
A new study investigated the antiviral activity and mechanism of action of Brilacidin against multiple human coronaviruses.
An editorial published today in The Lancet Neurology calls for sports authorities to take into consideration the long term neurological problems that repeated concussions can cause.
In a new study, scientists at the National Institutes of Health took a molecular-level journey into microtubules, the hollow cylinders inside brain cells that act as skeletons and internal highways.
› Verified 6 days ago
News Archive
In a randomized trial performed to help resolve the uncertainty about the optimal oxygen saturation therapy in extremely preterm infants, researchers found that targeting saturations of 85 percent to 89 percent compared with 91 percent to 95 percent had no significant effect on the rate of death or disability at 18 months, according to a study published by JAMA. The study is being released early online to coincide with its presentation at the Pediatric Academic Societies annual meeting.
Sorrento Therapeutics, Inc. announced today that it has entered into an exclusive licensing agreement to develop and commercialize multiple prespecified and undisclosed biosimilar or biobetter antibodies from Mabtech Limited, a holding company for premier antibody development and manufacturing companies in China.
A new study investigated the antiviral activity and mechanism of action of Brilacidin against multiple human coronaviruses.
An editorial published today in The Lancet Neurology calls for sports authorities to take into consideration the long term neurological problems that repeated concussions can cause.
In a new study, scientists at the National Institutes of Health took a molecular-level journey into microtubules, the hollow cylinders inside brain cells that act as skeletons and internal highways.
› Verified 6 days ago
Cresthaven Medical Supply Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2577 S Hamilton Rd, Columbus, Ohio 43232 Phone: (614) 600-1544 | |
Steel City Medical Supplies Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5900 Roche Dr, Columbus, Ohio 43229 Phone: (614) 406-1980 | |
Apria Healthcare Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2124 Citygate Dr, Columbus, Ohio 43219 Phone: (614) 351-5920 | |
Tamarkin Company Type: Community/Retail Pharmacy Location: 840 W 3rd Ave, Columbus, Ohio 43212 Phone: (614) 294-2344 | |
Giant Eagle Pharmacy #6513 Type: Pharmacy Location: 6867 East Broad Street, Columbus, Ohio 43213 Phone: (614) 866-3079 |